Scientific Online Resource System

Social Medicine

Sociomedical and psychological aspects of gastric cancer incidence in working age

Alexandar Nikolov

Abstract

Despite the recorded in last decades trend of decline in morbidity and mortality from gastric neoplasms, the gastric cancer remains one of the most common causes of death worldwide. Morbidity and mortality are particularly elevated in the active, working age - from 18 to 64 years. Stomach neoplasms have a strong impact on the quality of life of patients, changing their ability to work, social life and attitudes toward family and loved ones. These changed relationships  have also an impact on the social life and status of the patient's relatives.

The aim of the study is to present some of the social and psycho-emotional aspects of the gastric cancer morbidity of people in active and working age.

The results of the conducted studies proved the connection of the morbidity and mortality from oncological diseases and in particular of the neoplasms of the stomach with the sex and age of the patients. Gastric oncological diseases have a significant negative impact on the psyche, ability to work and social life of patients. The high number of patients in working age is a prerequisite for the implementation in many countries of screening programs for early diagnosis, which is also recommended for the Republic of Bulgaria.

Keywords

cancer morbidity, work capacity, malignant gastric tumors, screening programs, distress

Full Text


References

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, et al.: Gastric cancer: epidemiology, prevention, classification, and treatment. CMAR 10, 239–248, 2018. doi:10.2147/CMAR.S149619

Balakrishnan M, George R, Sharma A, and Graham DY: Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep 19, 36, 2017. doi:10.1007/s11894-017-0575-8

Karimi P, Islami F, Anandasabapathy S, Freedman ND, and Kamangar F: Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev 23, 700–713, 2014. doi:10.1158/1055-9965.epi-13-1057

Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: is it needed?. Gastrointest Endosc 2016; 84 (01) 18-28

Chisato Hamashima, Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines, Update version of the Japanese Guidelines for Gastric Cancer Screening, Japanese Journal of Clinical Oncology, Volume 48, Issue 7, July 2018, Pages 673–683, https://doi.org/10.1093/jjco/hyy077

Matsuzaka, Masashi et al. High Mortality Rate of Stomach Cancer Caused Not by High Incidence but Delays in Diagnosis in Aomori Prefecture, Japan. Asian Pacific journal of cancer prevention : APJCP vol. 17,10 4723-4727. 1 Oct. 2016, doi:10.22034/apjcp.2016.17.10.4723

Lee KJ, Inoue M, Otani T, et al. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer. 2006;118(9):2315-2321. doi:10.1002/ijc.21664

Kaptein AA, Morita S, Sakamoto J. Quality of life in gastric cancer. World J Gastroenterol. 2005;11(21):3189-3196. doi:10.3748/wjg.v11.i21.3189

Kong H, Kwon OK, Yu W. Changes of Quality of Life after Gastric Cancer Surgery. J Gastric Cancer. 2012 Sep;12(3):194-200. https://doi.org/10.5230/jgc.2012.12.3.194

Blazeby J.M. et al. Clinical and psychometric validation of a questionnaire module,the EORTC QLQ-STO 22, to assess quality of life in patientswith gastric cancer. European Journal of Cancer 40 (2004) 2260–2268

Lagergren P, Fayers P, Conroy T, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago–gastric junction and the stomach. European Journal of Cancer, Volume 43, Issue 14, 2007, p. 2066-2073, doi.org/10.1016/j.ejca.2007.07.005.

Maconi, G., Manes, G., & Porro, G. B. (2008). Role of symptoms in diagnosis and outcome of gastric cancer. World journal of gastroenterology, 14(8), 1149–1155. https://doi.org/10.3748/wjg.14.1149

Grace EM, Shaw C, Lalji A, Mohammed K, Andreyev HJN, et al. Nutritional status, the development and persistence of malnutrition and dietary intake in oesophago-gastric cancer: a longitudinal cohort study. J Hum Nutr Diet 31, 785, 2018. doi:10.1111/jhn.12588

Nordin K, and Glimelius B. Psychological Reactions in Newly Diagnosed Gastrointestinal Cancer Patients, Acta Oncologica, 1997, 36:8, 803-810, doi:10.3109/02841869709001361

Jeong A, An JY. The moderating role of social support on depression and anxiety for gastric cancer patients and their family caregivers. PLoS ONE, 2017, 12(12): e0189808. https://doi.org/10.1371/journal.pone.0189808 Accessed on 08.01.2020

Spiegel BM, Brennan MR et al. Understanding gastrointestinal distress: a framework for clinical practice. The American journal of gastroenterology vol. 106,3 (2011): 380-5. doi:10.1038/ajg.2010.383

Ye, ZJ, Qiu, HZ, Li, PF, et al. Predicting changes in quality of life and emotional distress in Chinese patients with lung, gastric, and colon‐rectal cancer diagnoses: the role of psychological resilience. Psycho‐Oncology. 2017; 26: 829– 835. https://doi.org/10.1002/pon.4237.

Bulgarian National Cancer Registry. Cancer Incidence in Bulgaria 2004. Editors Danon S, Valerianova Z and T. Ivanova Volume XV 2007.

Български национален раков регистър. Заболяемост от рак в България, 2014 и 2015. Ред: Валерианова З, Атанасов Т, Вуков М. Том XXV, 2017.

НСИ 2020. https://www.nsi.bg.

Hotz, J.; Meyer, H. -J.; Schmoll, H. -J. Magenkarzinom. Springer Berlin Heidelberg 1989. p. 45-77 ISBN 978-3-540-19001-1

Yusefi AR, Bagheri Lankarani K, Bastani P, Radinmanesh M, Kavosi Z. Risk factors for gastric cancer: a systematic review. Asian Pac J Cancer Prev 2018; 19 (03) 591-603

Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019; 14 (01) 26-38

Chong, SY & Ang SF. The Clinicopathological Features and Staging at Presentation of Gastric Cancer: A Single-Center Retrospective Study. Asian Journal of Oncology. (2020). DOI: 10.1055/s-0040-1714307 Open Access. Accessed on 14.07.2020

Hansson, L E et al. “Survival in stomach cancer is improving: results of a nationwide population-based Swedish study.” Annals of surgery vol. 230,2 (1999): 162-9. doi:10.1097/00000658-199908000-00005

Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303(17):1723-8

Wang Z, Xu J, Shi Z, Shen X, Luo T, Bi J, et al. Clinicopathologic characteristics and prognostic of gastric cancer in young patients. Scand J Gastroenterol. 2016;51(9):1043-9

Kouhestani M, Ahmadi Gharaei H, Fararouei M, et al. Global and regional geographical prevalence of depression in gastric cancer: a systematic review and meta-analysis BMJ Supportive & Palliative Care Published Online First: 20 May 2020. doi: 10.1136/bmjspcare-2019-002050 Accessed on 10.07.2020

Xia, R, Zeng, H, Liu, Q, et al. Health‐related quality of life and health utility score of patients with gastric cancer: A multi‐centre cross‐sectional survey in China. Eur J Cancer Care. 2020; 00:e13283. https://doi.org/10.1111/ecc.13283 Accessed 12.07.2020

Axon A: Symptoms and diagnosis of gastric cancer at early curable stage. Best Pract Res Clin Gastroenterol 20, 697–708, 2006. doi:10.1016/j.bpg.2006.03.015

Lin Y, Docherty SL, Porter LS, Bailey DE. Common and Co-Occurring Symptoms Experienced by Patients With Gastric Cancer. Oncol Nurs Forum. 2020 Mar;47(2) 187-202. doi:10.1188/20.onf.187-202. PMID: 32078617.

Han J, Tu J, Tang C, Ma X, Huang C. Clinicopathological characteristics and prognosis of cT1N0M1 gastric cancer: a population-based study. Dis Markers 2019; 2019: 5902091

Vahid F, Faghfoori Z, and Davoodi SH. The Impact of the Disease Trend on the Macro and Micro-Nutrients Intake in Patients with Gastric Cancer, Nutrition and Cancer, 2020, 72:6, 1036-1042, DOI: 10.1080/01635581.2019.1669677

Tian J and Chen JS: Nutritional status and quality of life of the gastric cancer patients in Changle County of China. World J Gastroenterol 11, 1582–1586, 2005.

Gavazzi C, Colatruglio S, Sironi A, Mazzaferro V, and Miceli R: Importance of early nutritional screening in patients with gastric cancer. Br J Nutr 106, 1773–1778, 2011. doi:10.1017/s0007114511002509

Coronavirus-Infektion (COVID-19) bei Patienten mit Blut- und Krebserkrankungen, www.onkopedia.com

Костадинов Р. Медицинско осигуряване на пациенти на продължителни грижи при бедствени ситуации. В „Актуални аспекти на продължителните грижи и палиативната медицина.“ Том I. под редакцията на проф. Л. Деспотова-Толева, Лакс Бук, Пловдив, 2016, стр. 71-78, ISBN 978-619-189-040-8

Костадинов Р. Предизвикателства на медицинското подпомагане при увредени и зависими от грижи пациенти при бедствия. В „Актуални аспекти на продължителните грижи и палиативната медицина.“ Том II. под редакцията на проф. Л. Деспотова-Толева, Лакс Бук, Пловдив, 2017, стр. 128-136. ISBN 978-619-189-062-0

Böhme B et al. Magenkrebs. Ein Ratgeber für Patientinnen und Patienten (1. Auflage Mai 2013). Berlin. https://www.krebshilfe.de/infomaterial/Patientenleitlinien/Magenkrebs_Patientenleitlinie_DeutscheKrebshilfe.pdf Accessed 20.01.2020

Nakajima S. Gastric Cancer Screening in Japan. In: Shiotani A. (eds) Gastric Cancer. 2019. Springer, Singapore doi.org/10.1007

Brenkman, H.J.F., Visser, E., van Rossum, P.S.N. et al. Association Between Waiting Time from Diagnosis to Treatment and Survival in Patients with Curable Gastric Cancer: A Population-Based Study in the Netherlands. Ann Surg Oncol 24, 1761–1769 (2017). https://doi.org/10.1245/s10434-017-5820-8

Miyamoto A, Kuriyama S, Nishino Y, et al. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Prev Med. 2007;44(1):12-19. doi:10.1016/j.ypmed.2006.07.016

Hamashima, Chisato et al. “Mortality reduction from gastric cancer by endoscopic and radiographic screening.” Cancer science vol. 106,12 (2015): 1744-9. doi:10.1111/cas.12829

Kato M, Asaka M. Recent knowledge of the relationship between Helicobacter pylori and gastric cancer and recent progress of gastroendoscopic diagnosis and treatment for gastric cancer. Jpn J Clin Oncol. 2010;40(9):828-837. doi:10.1093/jjco/hyq119

Sisik A, Kaya M, Bas G, Basak F, Alimoglu O. CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer Prev 2013; 14 (07) 4289-4294

Feng F, Tian Y, Xu G. et al. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer 2017; 17 (01) 737

Căinap C, Nagy V, Gherman A. et al. Classic tumor markers in gastric cancer. Current standards and limitations. Clujul Med 2015; 88 (02) 111-115

Проект BG051РО001-5.3.02-001-С0001 “СПРИ и се прегледай”, 21 май 2009 г. –21 октомври 2014 година.




DOI: http://dx.doi.org/10.14748/sm.v28i2.8659

Refbacks

Font Size


|